Clinical Trial Update: Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating a combination of sintilimab, pegaspagase, and GemOx (gemcitabine and oxaliplatin) for untreated extranoda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)
• Pegaspargase (pegaspargase)
• Sintilimab (sintilimab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Extranodal NK/T-cell Lymphoma | Phase 2 | Status: RECRUITING